• 13166 Citations
  • 40 h-Index
1973 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Article

The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma

Pápai, Z., Bodoky, G., Szánté, J., Poller, I., Rahóty, P., Eckhardt, S., Láng, I. & Szendröi, M., Jul 1 2000, In : Cancer. 89, 1, p. 177-180 4 p.

Research output: Contribution to journalArticle

26 Citations (Scopus)

The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005

Van Cutsem, E., Dicato, M., Arber, N., Benson, A., Cunningham, D., Diaz-Rubio, E., Glimelius, B., Goldberg, R., Haller, D., Haustermans, K., Koo-Kang, Y., Labianca, R., Lang, I., Minsky, B., Nordlinger, B., Roth, A., Rougier, P., Schmoll, H. J., Sobrero, A., Tabernero, J. & 2 others, Szawlowski, A. & van de Velde, C., Jun 2006, In : Annals of Oncology. 17, SUPPL. 6, p. vi13-vi18

Research output: Contribution to journalArticle

26 Citations (Scopus)
9 Citations (Scopus)

Therapeutic results: report of the Hungarian children's leukaemia study group

Schuler, D., Galfi, I., Istvan, L., Kassai, P., Kemény, P., Laub, M. W., Romhányi, J., Székely, K., Velkey, L., Virág, I. & Zimonyi, I., Dec 1 1976, In : Haematologia. 10, 1, p. 51-56 6 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

The superoxide scavenging activity of dihydroquinoline type derivatives (CH402 and MTDQ-DA)

Prònai, L., Blåzovics, A., Horvåth, M., Lång, I. & Fehér, J., Jan 1 1993, In : Free radical research. 19, 5, p. 287-296 10 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
6 Citations (Scopus)

Transfer factorral kezelt krónikus candidiasis esete

Translated title of the contribution: A case of chronic candidiasis treated with transfer factorNékám, K., Gürtler, A., Kalmár, L., Láng, I. & Petrányi, G., Dec 1 1975, In : Fogorvosi szemle. 68, 12, p. 369-372 4 p.

Research output: Contribution to journalArticle

Trastuzumab (Herceptin) a HER-2-pozitív korai emlorák adjuváns kezelésében

Translated title of the contribution: Trastuzumab (Herceptin) in the adjuvant teatment of HER-2-positive early breast cancerLáng, I. & Hitre, E., Dec 1 2006, In : Magyar onkologia. 50, 4, p. 293-302 10 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., Cameron, D., Dowsett, M., Barrios, C. H., Steger, G., Huang, C. S., Andersson, M., Inbar, M., Lichinitser, M., Láng, I., Nitz, U. & 12 others, Iwata, H., Thomssen, C., Lohrisch, C., Suter, T. M., Rüschoff, J., Süto, T., Greatorex, V., Ward, C., Straehle, C., McFadden, E., Dolci, M. S. & Gelber, R. D., Oct 20 2005, In : New England Journal of Medicine. 353, 16, p. 1659-1672 14 p.

Research output: Contribution to journalArticle

3737 Citations (Scopus)

Trastuzumab retreatment after relapse on adjuvant trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer: Final results of the retreatment after herceptin adjuvant trial

Láng, I., Bell, R., Feng, F. Y., Lopez, R. I., Jassem, J., Semiglazov, V., Al-Sakaff, N., Heinzmann, D. & Chang, J., Feb 2014, In : Clinical Oncology. 26, 2, p. 81-89 9 p.

Research output: Contribution to journalArticle

18 Citations (Scopus)

Treatment adherence and its impact on Disease-Free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequence

Chirgwin, J. H., Giobbie-Hurder, A., Coates, A. S., Price, K. N., Ejlertsen, B., Debled, M., Gelber, R. D., Goldhirsch, A., Smith, I., Rabaglio, M., Forbes, J. F., Neven, P., Láng, I., Colleoni, M. & Thürlimann, B., Jul 20 2016, In : Journal of Clinical Oncology. 34, 21, p. 2452-2459 8 p.

Research output: Contribution to journalArticle

77 Citations (Scopus)
6 Citations (Scopus)

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00

Pruneri, G., Gray, K. P., Vingiani, A., Viale, G., Curigliano, G., Criscitiello, C., Láng, I., Ruhstaller, T., Gianni, L., Goldhirsch, A., Kammler, R., Price, K. N., Cancello, G., Munzone, E., Gelber, R. D., Regan, M. M. & Colleoni, M., Jul 1 2016, In : Breast Cancer Research and Treatment. 158, 2, p. 323-331 9 p.

Research output: Contribution to journalArticle

58 Citations (Scopus)

Tumoros betegek csökkent természetes limfocitotoxicitásának fokozása transzfer faktor kezeléssel.

Translated title of the contribution: Enhancing decreased natural lymphocytotoxicity in tumor patients by transfer factor therapyLáng, I., Nékám, K., Gergely, P. & Petrányi, G., Apr 3 1983, In : Orvosi hetilap. 124, 14, p. 807-810 4 p.

Research output: Contribution to journalArticle

Twelve-month estrogen levels in premenopausal women with hormone receptor-positive breast cancer receiving adjuvant triptorelin plus exemestane or tamoxifen in the suppression of ovarian function trial (SOFT): The SOFT-EST substudy

Bellet, M., Gray, K. P., Francis, P. A., Láng, I., Ciruelos, E., Lluch, A., Climent, M. A., Catalán, G., Avella, A., Bohn, U., González-Martin, A., Ferrer, R., Catalán, R., Azaro, A., Rajasekaran, A., Morales, J., Vázquez, J., Fleming, G. F., Price, K. N. & Regan, M. M., May 10 2016, In : Journal of Clinical Oncology. 34, 14, p. 1584-1593 10 p.

Research output: Contribution to journalArticle

55 Citations (Scopus)

Újabb klinikai adatok a daganatos betegek anémiá jának erythropoetinkezelésében

István, L., Jan 1 2005, In : Magyar onkologia. 49, 3, p. 251-254 4 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Ujabb klinikai adatok a daganatos betegek anémiájának erythropoetinkezelésében. Az Amerikai Klinikai Onkológiai Társaság (ASCO) 2005. évi orlandói kongresszusán bemutatott fontosabb eredmények összefoglalása.

Translated title of the contribution: New clinical data on erythropoietin therapy of cancer patients with anemia. Summary of the major presentations at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, 2005Láng, I., 2005, In : Magyar Onkologia. 49, 3, p. 251-254 4 p.

Research output: Contribution to journalArticle

Vandetanib with docetaxel as second-line treatment for advanced breast cancer: A double-blind, placebo-controlled, randomized Phase II study

Boér, K., Láng, I., Llombart-Cussac, A., Andreasson, I., Vivanco, G. L., Sanders, N., Pover, G. M. & Murray, E., Apr 1 2012, In : Investigational New Drugs. 30, 2, p. 681-687 7 p.

Research output: Contribution to journalArticle

33 Citations (Scopus)

VERANDERUNGEN DER ZELLULAREN IMMUNITAT UNTER DER PERITONEALDIALYSE

Translated title of the contribution: Changes of the cellular immunity under the peritoneal dialysisTaraba, I., Lang, I., Gonzalez-Cabello, R. & Petranyi, G., Jan 1 1981, In : Zeitschrift fur die Gesamte Innere Medizin und Ihre Grenzgebiete. 36, 8, p. 269-272 4 p.

Research output: Contribution to journalArticle

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

Viale, G., Regan, M. M., Dell'Orto, P., Mastropasqua, M. G., Maiorano, E., Rasmussen, B. B., MacGrogan, G., Forbes, J. F., Paridaens, R. J., Colleoni, M., Láng, I., Thürlimann, B., Mouridsen, H., Mauriac, L., Gelber, R. D., Price, K. N., Goldhirsch, A., Gusterson, B. A. & Coates, A. S., Oct 2011, In : Annals of Oncology. 22, 10, p. 2201-2207 7 p.

Research output: Contribution to journalArticle

67 Citations (Scopus)